Effect of the dual 5α-reductase inhibitor Pnu 157706 on the growth of dunning R3327 prostatic carcinoma in the rat

This publication has 26 references indexed in Scilit:

• PNU 157706, a novel dual type I and II5α-reductase inhibitor
  The Journal of Steroid Biochemistry and Molecular Biology, 1998
• The potential for hormonal prevention trials
  Cancer, 1994
• 5α‐Reductase inhibitors and prostatic disease
  Clinical Endocrinology, 1994
• Systemic therapy of prostate cancer. new concepts from prostate cancer tumor biology
  Cancer Treatment Reviews, 1993
• Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy
  Cancer, 1993
• Response of rat and human prostatic cancers to the novel 5α‐reductase inhibitor, SK&F 105657
  The Prostate, 1992
• Quantitative assessment of endogenous testicular and adrenal sex steroids and of steroid metabolizing enzymes in untreated human prostatic cancerous tissue
  Journal of Steroid Biochemistry, 1988
• Establishment and characterization of seven dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers
  The Prostate, 1986
• ENDOGENOUS STEROID LEVELS IN THE HUMAN PROSTATE FROM BIRTH TO OLD AGE: A COMPARISON OF NORMAL AND DISEASED TISSUES
  Journal of Endocrinology, 1978
• Structural recognitions in the interactions of androgens and receptor proteins and in their association with nuclear acceptor components
  Journal of Steroid Biochemistry, 1972